Huili Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Huili Zhang has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
Jun Gu
Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, 200011 Shanghai, China
7 shared publicationsShuying Huang
Department of Cardiology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
6 shared publicationsJunfeng Zhang
Department of Cardiology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
5 shared publicationsChangqian Wang
Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4 shared publications- Changqian Wang
Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China
4 shared publications Huasu Zeng
Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, 200011 Shanghai, China
4 shared publications
Latest Publications
- Open Access
- 30 August 2026
- Published by Springer Nature in Cardiovascular Diabetology
Parturition attenuates endothelial senescence to resist nitrosative stress-induced heart failure with preserved ejection fraction in mice
Background: Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of heart failure patients and is biased toward elderly females. Nitrosative stress-induced HFpEF animal studies fail to phenocopy this sex bias and the underlying pathological mechanisms remain elusive.- Methods: In this study, we used nitrosative stress-induced HFpEF animal models and pharmacological methods to induce or reduce endothelial senescence. Findings: By examining HFpEF patients’ parturition history, we found that parous women showed an observational trend toward higher myocardial microperfusion than nulliparous women, although the perfusion difference did not reach statistical significance after FDR correction. To test whether parturition affects HFpEF progression, we compared primiparous and nulliparous mice using a high-fat diet and nitrosative stress-induced HFpEF model. Relative to nulliparous mice, primiparous HFpEF mice showed higher cardiac capillary density, attenuated endothelial and cardiomyocyte senescence, and delayed diastolic dysfunction. Pharmacological modulation confirmed endothelial senescence is a prerequisite for diastolic dysfunction and cardiomyocyte senescence. Endothelial cell media assays demonstrated senescent endothelial cells induce telomeric dysfunction in cardiomyocytes. Protein microarray screening further identified CXCL10 as the key paracrine factor driving cardiomyocyte senescence. Overexpression of modified telomerase protected myocardial telomeres and restored diastolic function in male and female HFpEF mice. Interpretation: These data support an important role for endothelial senescence in HFpEF pathogenesis and provide mechanistic evidence for endothelial-to-cardiomyocyte senescence signaling, although endothelial-specific causality remains to be established in vivo. Parturition is associated with reduced endothelial senescence and protection from HFpEF, and telomere reprotection may serve as a therapeutic strategy for HFpEF.
- 30 August 2026
- Published by Springer Nature in Cardiovascular Diabetology
Open AccessParturition attenuates endothelial senescence to resist nitrosative stress-induced heart failure with preserved ejection fraction in mice
Background: Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of heart failure patients and is biased toward elderly females. Nitrosative stress-induced HFpEF animal studies fail to phenocopy this sex bias and the underlying pathological mechanisms remain elusive.- Methods: In this study, we used nitrosative stress-induced HFpEF animal models and pharmacological methods to induce or reduce endothelial senescence. Findings: By examining HFpEF patients’ parturition history, we found that parous women showed an observational trend toward higher myocardial microperfusion than nulliparous women, although the perfusion difference did not reach statistical significance after FDR correction. To test whether parturition affects HFpEF progression, we compared primiparous and nulliparous mice using a high-fat diet and nitrosative stress-induced HFpEF model. Relative to nulliparous mice, primiparous HFpEF mice showed higher cardiac capillary density, attenuated endothelial and cardiomyocyte senescence, and delayed diastolic dysfunction. Pharmacological modulation confirmed endothelial senescence is a prerequisite for diastolic dysfunction and cardiomyocyte senescence. Endothelial cell media assays demonstrated senescent endothelial cells induce telomeric dysfunction in cardiomyocytes. Protein microarray screening further identified CXCL10 as the key paracrine factor driving cardiomyocyte senescence. Overexpression of modified telomerase protected myocardial telomeres and restored diastolic function in male and female HFpEF mice. Interpretation: These data support an important role for endothelial senescence in HFpEF pathogenesis and provide mechanistic evidence for endothelial-to-cardiomyocyte senescence signaling, although endothelial-specific causality remains to be established in vivo. Parturition is associated with reduced endothelial senescence and protection from HFpEF, and telomere reprotection may serve as a therapeutic strategy for HFpEF.
- Open Access
- 25 February 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (2)
Association of Thyroid Function With Restenosis and Long-Term Outcomes After Drug-Coated Balloon Angioplasty in Euthyroid Patients With Coronary Heart Disease
Background: The role of euthyroid hormone levels in clinical outcomes after drug-coated balloon (DCB) angioplasty in patients with coronary heart disease (CHD) remains unclear. Thus, this study aimed to explore the relationship between thyroid function and the risk of restenosis at one year, as well as the prognosis over five years in euthyroid patients with CHD following DCB angioplasty. Methods: This prospective study evaluated 189 euthyroid CHD patients who underwent successful DCB angioplasty. Coronary angiographic follow-up was performed 9–12 months post-procedure to assess the status of target lesions, with restenosis defined as ≥50% reduction in luminal diameter. All patients underwent five-year clinical follow-ups, during which major adverse cardiovascular events (MACEs) were recorded. Results: Following angiographic follow-ups, patients were categorized into two groups: those with restenosis (n = 66) and those without (n = 123). At baseline and during the follow-up, the restenosis group demonstrated significantly higher levels of thyroid-stimulating hormone (TSH), lymphocytes, hemoglobin A1c (HbA1c), lipoprotein(a), and platelet count, along with lower free triiodothyronine (FT3) levels. Multivariable logistic regression analysis revealed that the TSH levels both at the baseline (odds ratio (OR) 1.607, 95% confidence interval (CI) 1.238–2.085, p < 0.001) and angiographic follow-up (OR 2.970, 95% CI 2.000–4.411, p < 0.001) were independently associated with an increased risk of post-DCB restenosis. Furthermore, patients in the high TSH tertile had a 90% increased risk of MACEs during the 5-year follow-up period (hazard ratio (HR) 1.922, 95% CI 1.343–2.750, p < 0.001) compared with those in the low TSH tertile. Conclusions: A high-normal TSH level within the euthyroid range was strongly associated with an increased 1-year restenosis risk and decreased 5-year MACE-free survival following DCB angioplasty in CHD patients.
- 25 February 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (2)
Open AccessAssociation of Thyroid Function With Restenosis and Long-Term Outcomes After Drug-Coated Balloon Angioplasty in Euthyroid Patients With Coronary Heart Disease
Background: The role of euthyroid hormone levels in clinical outcomes after drug-coated balloon (DCB) angioplasty in patients with coronary heart disease (CHD) remains unclear. Thus, this study aimed to explore the relationship between thyroid function and the risk of restenosis at one year, as well as the prognosis over five years in euthyroid patients with CHD following DCB angioplasty. Methods: This prospective study evaluated 189 euthyroid CHD patients who underwent successful DCB angioplasty. Coronary angiographic follow-up was performed 9–12 months post-procedure to assess the status of target lesions, with restenosis defined as ≥50% reduction in luminal diameter. All patients underwent five-year clinical follow-ups, during which major adverse cardiovascular events (MACEs) were recorded. Results: Following angiographic follow-ups, patients were categorized into two groups: those with restenosis (n = 66) and those without (n = 123). At baseline and during the follow-up, the restenosis group demonstrated significantly higher levels of thyroid-stimulating hormone (TSH), lymphocytes, hemoglobin A1c (HbA1c), lipoprotein(a), and platelet count, along with lower free triiodothyronine (FT3) levels. Multivariable logistic regression analysis revealed that the TSH levels both at the baseline (odds ratio (OR) 1.607, 95% confidence interval (CI) 1.238–2.085, p < 0.001) and angiographic follow-up (OR 2.970, 95% CI 2.000–4.411, p < 0.001) were independently associated with an increased risk of post-DCB restenosis. Furthermore, patients in the high TSH tertile had a 90% increased risk of MACEs during the 5-year follow-up period (hazard ratio (HR) 1.922, 95% CI 1.343–2.750, p < 0.001) compared with those in the low TSH tertile. Conclusions: A high-normal TSH level within the euthyroid range was strongly associated with an increased 1-year restenosis risk and decreased 5-year MACE-free survival following DCB angioplasty in CHD patients.
- 31 October 2025
- Published by Springer Nature in GeroScience
- Vol. 48 (4) , 1-13
Leukocyte telomere length and risk of heart failure with preserved ejection fraction in high-risk Chinese patients with hypertension under 65 years
Shorter leukocyte telomere length (LTL) is associated with aging-related cardiovascular diseases, but its relationship with heart failure with preserved ejection fraction (HFpEF) in high-risk Chinese patients with hypertension under 65 years remains unclear. In this observational prospective study, we investigated 646 patients with hypertension aged < 65 years with diabetes, coronary heart disease (CHD), or ≥ 3 cardiovascular risk factors. Baseline assessments included clinical evaluation, measurement of aging markers (LTL and mitochondrial DNA copy number) and echocardiography. Participants underwent scheduled quarterly follow-up for 5 years, with documentation of major adverse cardiovascular events (MACEs), including cardiovascular mortality, myocardial infarction, ischemia-driven revascularization, stroke and heart failure hospitalization. At the final follow-up visit, the evaluation for HFpEF was performed through echocardiography and plasma B-type natriuretic peptide (BNP) measurement. Participants were stratified by LTL tertiles: long (> 79.89; n = 216), mid (58.49–79.89; n = 214), and short (< 58.49; n = 216). Compared with the long and mid LTL groups, the short LTL group had a higher prevalence of male, smoking, hyperlipidemia, diabetes, and CHD, along with elevated blood pressure and fasting blood glucose, but lower mitochondrial DNA copy number (all P < 0.05). At 5-year follow-up, HFpEF prevalence increased with shorter LTL (15.7%,11.2% and 7.9% across LTL tertiles, p = 0.037). Multivariable logistic regression analysis identified shorter LTL as an independent predictor of HFpEF (adjusted OR 2.087, 95% CI: 1.017, 4.280, p = 0.045), in addition to CHD, uric acid, and C-reactive protein. Compared with the long LTL group, both the short (adjusted hazard ratio [HR] 1.953, 95% CI 1.259–3.028; P = 0.003) and mid LTL groups (adjusted HR 1.581, 95% CI: 1.015–2.464, P = 0.043) showed a significantly increased risk of 5-year MACE. In conclusion, shorter LTL independently predicts HFpEF development and adverse cardiovascular outcomes in high-risk Chinese patients with hypertension under 65 years, suggesting telomere biology may contribute to HFpEF pathogenesis and clinical outcomes in this population.
- 31 October 2025
- Published by Springer Nature in GeroScience
- Vol. 48 (4) , 1-13
Leukocyte telomere length and risk of heart failure with preserved ejection fraction in high-risk Chinese patients with hypertension under 65 years
Shorter leukocyte telomere length (LTL) is associated with aging-related cardiovascular diseases, but its relationship with heart failure with preserved ejection fraction (HFpEF) in high-risk Chinese patients with hypertension under 65 years remains unclear. In this observational prospective study, we investigated 646 patients with hypertension aged < 65 years with diabetes, coronary heart disease (CHD), or ≥ 3 cardiovascular risk factors. Baseline assessments included clinical evaluation, measurement of aging markers (LTL and mitochondrial DNA copy number) and echocardiography. Participants underwent scheduled quarterly follow-up for 5 years, with documentation of major adverse cardiovascular events (MACEs), including cardiovascular mortality, myocardial infarction, ischemia-driven revascularization, stroke and heart failure hospitalization. At the final follow-up visit, the evaluation for HFpEF was performed through echocardiography and plasma B-type natriuretic peptide (BNP) measurement. Participants were stratified by LTL tertiles: long (> 79.89; n = 216), mid (58.49–79.89; n = 214), and short (< 58.49; n = 216). Compared with the long and mid LTL groups, the short LTL group had a higher prevalence of male, smoking, hyperlipidemia, diabetes, and CHD, along with elevated blood pressure and fasting blood glucose, but lower mitochondrial DNA copy number (all P < 0.05). At 5-year follow-up, HFpEF prevalence increased with shorter LTL (15.7%,11.2% and 7.9% across LTL tertiles, p = 0.037). Multivariable logistic regression analysis identified shorter LTL as an independent predictor of HFpEF (adjusted OR 2.087, 95% CI: 1.017, 4.280, p = 0.045), in addition to CHD, uric acid, and C-reactive protein. Compared with the long LTL group, both the short (adjusted hazard ratio [HR] 1.953, 95% CI 1.259–3.028; P = 0.003) and mid LTL groups (adjusted HR 1.581, 95% CI: 1.015–2.464, P = 0.043) showed a significantly increased risk of 5-year MACE. In conclusion, shorter LTL independently predicts HFpEF development and adverse cardiovascular outcomes in high-risk Chinese patients with hypertension under 65 years, suggesting telomere biology may contribute to HFpEF pathogenesis and clinical outcomes in this population.
- Top Cited PapersOpen Access
- 29 January 2024
- Published by Elsevier in Redox Biology
- Vol. 70, 103066
Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11/GSH/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation
- 29 January 2024
- Published by Elsevier in Redox Biology
- Vol. 70, 103066
Top Cited PapersOpen AccessHydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11/GSH/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation
- Open Access
- 9 November 2023
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (11) , 314
Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease
Background: Lipid profiles differ naturally between individuals and between populations. So far, the data relating to non-fasting lipid profiles has been derived predominantly from studies on Western population. The characteristics and clinical significance of non-fasting lipids in Chinese patients with coronary heart disease (CHD) in response to traditional Chinese diets remain poorly understood. Methods: A total of 1022 Chinese CHD patients with coronary artery luminal stenosis >40% as diagnosed by coronary artery angiography were enrolled in the study. All patients received standard treatment for CHD, including statins. They were divided into an intermediate stenosis group (luminal stenosis 40–70%, n = 486) or a severe stenosis group (luminal stenosis >70%, n = 536). Their blood lipid profiles were measured in the fasting state, and 4 hours after normal breakfast. All participants were followed up for five years. Major adverse cardiovascular events (MACE) including all-cause death, cardiac death, myocardial infarction, unscheduled coronary revascularization and stroke were recorded. Results: After normal breakfast intake, patients with intermediate or severe stenosis showed an apparent increase in the levels of triglyceride (TG), remnant cholesterol (RC) and Apo (apolipoprotein) A1 compared to the fasting state, but a significant reduction in the levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), Apo B and Apo E. In addition to the traditional risk factors (older age, male, diabetes and smoking) and coronary artery stenosis, the fasting levels of LDL-C and Apo B, as well as non-fasting levels of HDL-C and Apo A1, were identified as independent predictors of 5-year MACE occurrence by multivariate Cox proportional hazards analysis. Patients in the 1st tertile of the non-fasting HDL-C group (1.07 mmol/L) (1st tertile: 2.786, 95% CI (confidence intervals) [1.808, 4.293], p < 0.001). Conclusions: This prospective observational study found that lipid profiles in either the fasting or non-fasting states were associated with the long-term risk of MACE in Chinese CHD patients. In addition to the fasting LDL-C level, a low non-fasting HDL-C level may also be an independent risk factors for cardiovascular events. Measurement of lipid profiles during the non-fasting state may be feasible for the management of CHD patients in routine clinical practice in China.
- 9 November 2023
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (11) , 314
Open AccessClinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease
Background: Lipid profiles differ naturally between individuals and between populations. So far, the data relating to non-fasting lipid profiles has been derived predominantly from studies on Western population. The characteristics and clinical significance of non-fasting lipids in Chinese patients with coronary heart disease (CHD) in response to traditional Chinese diets remain poorly understood. Methods: A total of 1022 Chinese CHD patients with coronary artery luminal stenosis >40% as diagnosed by coronary artery angiography were enrolled in the study. All patients received standard treatment for CHD, including statins. They were divided into an intermediate stenosis group (luminal stenosis 40–70%, n = 486) or a severe stenosis group (luminal stenosis >70%, n = 536). Their blood lipid profiles were measured in the fasting state, and 4 hours after normal breakfast. All participants were followed up for five years. Major adverse cardiovascular events (MACE) including all-cause death, cardiac death, myocardial infarction, unscheduled coronary revascularization and stroke were recorded. Results: After normal breakfast intake, patients with intermediate or severe stenosis showed an apparent increase in the levels of triglyceride (TG), remnant cholesterol (RC) and Apo (apolipoprotein) A1 compared to the fasting state, but a significant reduction in the levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), Apo B and Apo E. In addition to the traditional risk factors (older age, male, diabetes and smoking) and coronary artery stenosis, the fasting levels of LDL-C and Apo B, as well as non-fasting levels of HDL-C and Apo A1, were identified as independent predictors of 5-year MACE occurrence by multivariate Cox proportional hazards analysis. Patients in the 1st tertile of the non-fasting HDL-C group (1.07 mmol/L) (1st tertile: 2.786, 95% CI (confidence intervals) [1.808, 4.293], p < 0.001). Conclusions: This prospective observational study found that lipid profiles in either the fasting or non-fasting states were associated with the long-term risk of MACE in Chinese CHD patients. In addition to the fasting LDL-C level, a low non-fasting HDL-C level may also be an independent risk factors for cardiovascular events. Measurement of lipid profiles during the non-fasting state may be feasible for the management of CHD patients in routine clinical practice in China.
- 12 May 2023
- Published by Elsevier in Nitric Oxide
- Vol. 136-137, 12-23
Hydrogen sulfide alleviates heart failure with preserved ejection fraction in mice by targeting mitochondrial abnormalities via PGC-1α
- 12 May 2023
- Published by Elsevier in Nitric Oxide
- Vol. 136-137, 12-23
Hydrogen sulfide alleviates heart failure with preserved ejection fraction in mice by targeting mitochondrial abnormalities via PGC-1α
- Open Access
- 14 February 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (1) , e0195622
Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension
Our study fills the gap in human studies investigating the oral and gut fungal microbiota in association with blood pressure. It characterizes the diversity and composition of the oral and gut fungal microbiome in human subjects, elucidates the dysbiosis of fungal ecology in a hypertensive population, and establishes oral-gut fungal correlations and fungus-clinical parameter correlations.
- 14 February 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (1) , e0195622
Open AccessCharacteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension
Our study fills the gap in human studies investigating the oral and gut fungal microbiota in association with blood pressure. It characterizes the diversity and composition of the oral and gut fungal microbiome in human subjects, elucidates the dysbiosis of fungal ecology in a hypertensive population, and establishes oral-gut fungal correlations and fungus-clinical parameter correlations.
- Open Access
- 7 November 2022
- Published by Springer Nature in Research Square
Fasting and non-fasting lipoproteins and apolipoproteins for long-term outcome prediction in Chinese patients with coronary heart disease:a prospective observational study
Background Within 24 hours a day, people are mostly in a non-fasting state. However, little is known about the characteristics and clinical significance of non-fasting lipids in Chinese population with coronary heart disease (CHD) in response to traditional Chinses diets. Methods A total number of 1022 Chinese CHD patients with coronary artery luminal stenosis more than 40% diagnosed by coronary artery angiography were enrolled. All the patients received the routine treatment for CHD, including statins. They were divided into intermediate stenosis group (luminal stenosis 40–70%, n = 486) or severe stenosis group (luminal stenosis > 70%, n = 536). Their blood lipid profiles were measured in the fasting state or 4 hours after normal breakfast. All the participants followed up for five years. Major adverse cardiovascular events (MACE) including all cause death, cardiac death, myocardial infarction, unscheduled coronary revascularization and stroke were recorded. Results After normal breakfast intake, patients with either intermediate or severe stenosis had an apparent increase from the fasting state in the levels of TG, remnant cholesterol (RC) and ApoA1, but a significant reduction in the levels of total cholesterol (TC), LDL-C, non-HDL-C, Apo B and Apo E. Multivariate logistic regression models showed that both the fasting and non-fasting levels of HDL-C and Apo A1 was negatively associated with the severity of coronary artery stenosis. In addition to the traditional risk factors (age, male, diabetes and smoking) and the severity of coronary artery stenosis, both the fasting and non-fasting levels of lipoproteins (LDL-C and HDL-C) and apolipoproteins (Apo A1 and Apo B) were identified as independent predictors of 5-year MACE occurrence by multivariate Cox proportional hazards analysis. Conclusion This prospective observational study demonstrated that the levels of lipoproteins and apolipoproteins in either fasting or non-fasting state were highly associated with the long-term risk of MACE in Chinses CHD patients. Measurements of lipid profiles in the non-fasting state may be feasible for CHD management in routine clinical practice in China.
- 7 November 2022
- Published by Springer Nature in Research Square
Open AccessFasting and non-fasting lipoproteins and apolipoproteins for long-term outcome prediction in Chinese patients with coronary heart disease:a prospective observational study
Background Within 24 hours a day, people are mostly in a non-fasting state. However, little is known about the characteristics and clinical significance of non-fasting lipids in Chinese population with coronary heart disease (CHD) in response to traditional Chinses diets. Methods A total number of 1022 Chinese CHD patients with coronary artery luminal stenosis more than 40% diagnosed by coronary artery angiography were enrolled. All the patients received the routine treatment for CHD, including statins. They were divided into intermediate stenosis group (luminal stenosis 40–70%, n = 486) or severe stenosis group (luminal stenosis > 70%, n = 536). Their blood lipid profiles were measured in the fasting state or 4 hours after normal breakfast. All the participants followed up for five years. Major adverse cardiovascular events (MACE) including all cause death, cardiac death, myocardial infarction, unscheduled coronary revascularization and stroke were recorded. Results After normal breakfast intake, patients with either intermediate or severe stenosis had an apparent increase from the fasting state in the levels of TG, remnant cholesterol (RC) and ApoA1, but a significant reduction in the levels of total cholesterol (TC), LDL-C, non-HDL-C, Apo B and Apo E. Multivariate logistic regression models showed that both the fasting and non-fasting levels of HDL-C and Apo A1 was negatively associated with the severity of coronary artery stenosis. In addition to the traditional risk factors (age, male, diabetes and smoking) and the severity of coronary artery stenosis, both the fasting and non-fasting levels of lipoproteins (LDL-C and HDL-C) and apolipoproteins (Apo A1 and Apo B) were identified as independent predictors of 5-year MACE occurrence by multivariate Cox proportional hazards analysis. Conclusion This prospective observational study demonstrated that the levels of lipoproteins and apolipoproteins in either fasting or non-fasting state were highly associated with the long-term risk of MACE in Chinses CHD patients. Measurements of lipid profiles in the non-fasting state may be feasible for CHD management in routine clinical practice in China.
- Open Access
- 7 June 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (11) , e024582
p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction
Background: Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of patients with heart failure. Clinically, HFpEF prevalence shows age and gender biases. Although the majority of patients with HFpEF are elderly, there is an emergence of young patients with HFpEF. A better understanding of the underlying pathogenic mechanism is urgently needed. Here, we aimed to determine the role of aging in the pathogenesis of HFpEF. Methods and Results: HFpEF dietary regimen (high‐fat diet + Nω‐Nitro‐L‐arginine methyl ester hydrochloride) was used to induce HFpEF in wild type and telomerase RNA knockout mice (second‐generation and third‐generation telomerase RNA component knockout), an aging murine model. First, both male and female animals develop HFpEF equally. Second, cardiac wall thickening preceded diastolic dysfunction in all HFpEF animals. Third, accelerated HFpEF onset was observed in second‐generation telomerase RNA component knockout (at 6 weeks) and third‐generation telomerase RNA component knockout (at 4 weeks) compared with wild type (8 weeks). Fourth, we demonstrate that mitochondrial respiration transitioned from compensatory state (normal basal yet loss of maximal respiratory capacity) to dysfunction (loss of both basal and maximal respiratory capacity) in a p53 dosage dependent manner. Last, using myocardial‐specific p53 knockout animals, we demonstrate that loss of p53 activation delays the development of HFpEF. Conclusions: Here we demonstrate that p53 activation plays a role in the pathogenesis of HFpEF. We show that short telomere animals exhibit a basal level of p53 activation, mitochondria upregulate mtDNA encoded genes as a mean to compensate for blocked mitochondrial biogenesis, and loss of myocardial p53 delays HFpEF onset in high fat diet + Nω‐Nitro‐L‐arginine methyl ester hydrochloride challenged murine model.
- 7 June 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (11) , e024582
Open Accessp53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction
Background: Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of patients with heart failure. Clinically, HFpEF prevalence shows age and gender biases. Although the majority of patients with HFpEF are elderly, there is an emergence of young patients with HFpEF. A better understanding of the underlying pathogenic mechanism is urgently needed. Here, we aimed to determine the role of aging in the pathogenesis of HFpEF. Methods and Results: HFpEF dietary regimen (high‐fat diet + Nω‐Nitro‐L‐arginine methyl ester hydrochloride) was used to induce HFpEF in wild type and telomerase RNA knockout mice (second‐generation and third‐generation telomerase RNA component knockout), an aging murine model. First, both male and female animals develop HFpEF equally. Second, cardiac wall thickening preceded diastolic dysfunction in all HFpEF animals. Third, accelerated HFpEF onset was observed in second‐generation telomerase RNA component knockout (at 6 weeks) and third‐generation telomerase RNA component knockout (at 4 weeks) compared with wild type (8 weeks). Fourth, we demonstrate that mitochondrial respiration transitioned from compensatory state (normal basal yet loss of maximal respiratory capacity) to dysfunction (loss of both basal and maximal respiratory capacity) in a p53 dosage dependent manner. Last, using myocardial‐specific p53 knockout animals, we demonstrate that loss of p53 activation delays the development of HFpEF. Conclusions: Here we demonstrate that p53 activation plays a role in the pathogenesis of HFpEF. We show that short telomere animals exhibit a basal level of p53 activation, mitochondria upregulate mtDNA encoded genes as a mean to compensate for blocked mitochondrial biogenesis, and loss of myocardial p53 delays HFpEF onset in high fat diet + Nω‐Nitro‐L‐arginine methyl ester hydrochloride challenged murine model.
- Top Cited PapersOpen Access
- 19 March 2022
- Published by Elsevier in Journal of Advanced Research
- Vol. 43, 147-161
Roles of oral microbiota and oral-gut microbial transmission in hypertension
- 19 March 2022
- Published by Elsevier in Journal of Advanced Research
- Vol. 43, 147-161
Top Cited PapersOpen AccessRoles of oral microbiota and oral-gut microbial transmission in hypertension